by Brooke Blazr | May 1, 2026 | High Dispatch
Per the White House’s own fact sheet, the executive order does several things. It directs the FDA Commissioner to issue National Priority Vouchers to psychedelic drugs that have already received Breakthrough Therapy designation, which is meant to speed up the...
by Brooke Blazr | Apr 30, 2026 | High Dispatch
What should a modern cannabis dispensary feel like? For years, the answer leaned clinical or transactional—think bright lights and glass counters. There was a quiet sense that you needed to know what you were doing before you walked in. Seaweed RBNY turned that...
by Brooke Blazr | Apr 30, 2026 | High Dispatch
Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine....
by Brooke Blazr | Apr 28, 2026 | High Dispatch
The best pipe for smoking weed shouldn’t have to hide in a drawer. Today’s cannabis consumers are done with fragile, disposable pieces. They want precision-engineered tools that look as good as they perform. A premium marijuana pipe can be both functional and...
by Brooke Blazr | Apr 28, 2026 | High Dispatch
There was a moment—not long ago—when industrial hemp stood for something real: a second chance for American farmers, a new industrial base, and a pathway to rebuild rural economies. When Donald Trump signed the 2018 Farm Bill—containing the Hemp Farming Act...
by Brooke Blazr | Apr 27, 2026 | High Dispatch
Let’s get one thing straight before the spin machine buries it: the federal rescheduling of cannabis from Schedule I to Schedule III did not happen because Donald Trump had a change of heart about the plant. He didn’t wake up one morning with a profound...
